KATRINSPENGLER Institute of Molecular Cell Biology, Center for Molecular Biomedicine,
Jena University Hospital, Jena, Germany
EDUARDOB. STERNICK Instituto de Pos-Graduac ̧a ̃o, Faculdade de Cieˆncias Me ́dicas de
Minas Gerais, Belo Horizonte, Brazil
PIERRESUJOBERT Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d’He ́
matologie Biologique, Pierre-Be ́nite, France; Universite ́ Claude Bernard Lyon-1,
Lyon, France; INSERM U1052, CNRS 5286, Universite ́ Claude Bernard, Faculte ́de
Me ́decine Lyon-Sud Charles Me ́rieux, Universite ́ de Lyon, Lyon, France
JE ́ROˆMETAMBURINI U1016, Institut Cochin, Inserm, Paris, France; UMR8104, CNRS,
Paris, France; Universite ́ Paris Descartes, Paris, France; Equipe Labellise ́e Ligue Nationale
Contre le Cancer (LNCC), Paris, France
MARINETHERET The Biomedical Research Centre, University of British Columbia,
Vancouver, BC, Canada; Faculty of Medicine, The University of British Columbia,
Vancouver, BC, Canada; Institut NeuroMyogene, CNRS UMR 5310, INSERM U1217, Universite ́ Claude Bernard Lyon 1, Villeurbanne, France JO ̈RGVERVOORTS Institute of Biochemistry and Molecular Biology, Medical School, RWTH Aachen University, Aachen, Germany GUILLAUMEVIAL INSERM U1042, Laboratoire Hypoxie-Physiopathologies cardiovasculaires et respiratoires HP2, Faculte ́deme ́decine et de pharmacie, Domaine de la merci, La Tronche, France; Universite ́ Grenoble-Alpes, Laboratoire Hypoxie- Physiopathologies cardiovasculaires et respiratoires HP2, Faculte ́deme ́decine et de pharmacie, Domaine de la merci, La Tronche, France ROSAVIANA Instituto de Biomedicina de Valencia, CSIC and Centro de Investigacion Biome ́dica en Red de Enfermedades Raras (CIBERER), Valencia, Spain VALE ́RIEVINGTDEUX Univ. Lille, Inserm, CHU Lille, UMR-S 1172—JPArc—Centre de Recherche Jean-Pierre AUBERT, Lille, France BENOITVIOLLET U1016, Department EMD, Institut Cochin, Inserm, Paris, France; UMR8104, CNRS, Paris, France; Universite ́ Paris Descartes, Paris, France QILONGWANG Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA, USA JESSICAWARD Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA WOLFRAMWECKWERTH Department of Ecogenomics and Systems Biology, University of Vienna, Vienna, Austria; Vienna Metabolomics Center (VIME), University of Vienna, Vienna, Austria MICHELEWEISS-GAYET Institut NeuroMyoge`ne, CNRS UMR 5310, INSERM U1217,
Universite ́ Claude Bernard Lyon 1, Villeurbanne, France
GRAHAMM. WEST Worldwide Research and Development, Pfizer Inc., Groton, CT, USA
JONR. WILSON The Francis Crick Institute, London, UK
JANEM. WITHKA Worldwide Research and Development, Pfizer Inc., Groton, CT, USA
JØRGENF. P. WOJTASZEWSKI Section of Molecular Physiology, Department of Nutrition,
Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark
BINGXIAO The Francis Crick Institute, London, UK
ARASHYAVARI Experimental Therapeutics, Radcliffe Department of Medicine, University of
Oxford, Oxford, UK; Division of Cardiovascular Medicine, Radcliffe Department of
Medicine, University of Oxford, Oxford, UK; The Wellcome Centre for Human Genetics,
University of Oxford, Oxford, UK
xvi Contributors